Recommended Topic Related To:

Lastacaft

"The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflam"...

Lastacaft

INDICATIONS

LASTACAFT™ (alcaftadine ophthalmic solution) is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.

DOSAGE AND ADMINISTRATION

Instill one drop in each eye once daily.

HOW SUPPLIED

Dosage Forms And Strengths

Topical ophthalmic solution containing alcaftadine, 0.25% (2.5 mg/mL).

Storage And Handling

LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% is supplied in an opaque, white low-density polyethylene bottle with a white polypropylene cap.

3 mL fill in 5 mL bottle (NDC 68669-41203)

Storage: Store at 15-25°C (59-77°F)

Manufactured for Vistakon Pharmaceuticals, LLC., Jacksonville, FL 32256 USA

Last reviewed on RxList: 8/20/2010
This monograph has been modified to include the generic and brand name in many instances.

A A A

Lastacaft - User Reviews

Lastacaft User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Lastacaft sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.